Trade Mark Journal No.2026/040 2 October 2026

WO0000001938143 (10)

Office of origin: United States of America

Date of International Registration:30 June 2026
Date of designation in the UK: 30 June 2026
Image for mark 1938143 NEUROTUNE

International priority date claimed: 6 January 2026 (United States of America) (99579849)
Class 10
Component feature of an implantable spinal cord stimulation system comprised primarily of implantable pulse generators (IPGs), electrical leads, external trial stimulators, and external therapy controllers, namely, a non-downloadable software feature for use in setting a sub-perception therapy mode for use in the treatment of pain.

Boston Scientific Neuromodulation Corporation

Representative: Barker Brettell LLP, 100 Hagley Road, Edgbaston Birmingham B16 8QQ UNITED KINGDOM